Drugs / MMR
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02825368 Comparator | Sep 2016 → Aug 2017 | — | McMaster University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MMR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02825368 ↗ |
| Modality | Vaccine | “conventional vaccine group” NCT02825368 ↗ |
| Route | Subcutaneous | “0.5 mL, subcutaneous” NCT02825368 ↗ |